首页> 外文OA文献 >Affinity Binding Macroporous Monolithic Cryogel as a Matrix for Extracorporeal Apheresis Medical Devices
【2h】

Affinity Binding Macroporous Monolithic Cryogel as a Matrix for Extracorporeal Apheresis Medical Devices

机译:亲和力结合大孔整体式冷冻凝胶作为体外置换医疗设备的基质。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Cytapheresis is an extracorporeal separation technique widely used in medicine for elimination of specific classesof blood cells from circulating blood. It has been shown recently to have clinical efficacy in various disease states, such as leukaemia, autoimmune disorders, rheumatoid arthritis, renal allograft rejection and sickle–cell anaemia. The current study was undertaken to produce an affinity-binding column, based upon a macroporous monolithic cryogel with a structure of interconnected pores, with pore size and low flow resistance potentially suitable for use in cytapheresis. The affinity column was produced from poly (2-hydroxyethyl methacrylate) PHEMA cryogels synthesized by free radical polymerization at -12°C. This study involved assessing haemolytic potential, and functionalisation of polymer matrix with biological ligands. Haemolytic potential of poly (2-hydroxyethyl methacrylate) cryogel was established by measuring free haemoglobin after blood filtration through the column. The anti-human albumin (antibody) was chemically coupled to the epoxy derivatised monolithic cryogels and the binding efficiency of anti-human albumin (antibody) to the cryogel was determined. Our results show that approximately 100% of Red blood cells passed through the column with no evidence of haemolysis found in blood eluted. It was found that ~82% of human serum albumin was retained on the monolithic IgG anti-human albumin cryogel matrix. The obtained results suggest that poly (2-hydroxyethyl methacrylate) monolithic cryogel is a non-haemolytic material (haemocompatible matrix) capable of functionalisation with antibody and thus can be an appropriate matrix for use inextracorporeal apheresis system.
机译:胞饮分离术是一种体外分离技术,广泛用于医学中,用于从循环血液中消除特定种类的血细胞。最近已显示它在各种疾病状态下均具有临床疗效,例如白血病,自身免疫性疾病,类风湿性关节炎,肾移植排斥反应和镰状细胞性贫血。正在进行当前的研究以基于具有连通的孔结构的大孔整体式冷冻凝胶生产亲和结合柱,其孔径和低流动阻力可能适用于细胞穿刺术。亲和柱是由在-12℃通过自由基聚合合成的聚(甲基丙烯酸2-羟乙酯)PHEMA凝胶制成的。这项研究涉及评估溶血的潜力,并用生物配体功能化聚合物基质。聚(2-甲基丙烯酸羟乙酯)冷冻凝胶的溶血潜力是通过在通过色谱柱进行血液过滤后测量游离血红蛋白来确定的。将抗人白蛋白(抗体)化学偶联至环氧衍生的整体式冷冻凝胶,并测定抗人白蛋白(抗体)与冷冻凝胶的结合效率。我们的结果表明,大约100%的红细胞通过色谱柱,而没有发现血液中溶血的迹象。已发现约82%的人血清白蛋白保留在单片IgG抗人白蛋白冷冻凝胶基质上。所获得的结果表明,聚(甲基丙烯酸2-羟乙酯)整体式冷冻凝胶是一种能够通过抗体进行功能化的非溶血性材料(血液相容性基质),因此可以用作体外单采血液分离系统的合适基质。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号